genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Hyperparathyroidism
Industry News
FDA Rejects Amgen’s Kidney Disease Candidate Parsabiv
Drug Discovery
VFMCRP to Develop OPKO Health’s Rayaldee in Some Ex-U.S. Markets
News
FDA Halts Amgen Sensipar Trials After Patient Dies
Industry News
Amgen to Pick Up Peptide Drug Firm KAI Pharmaceuticals for $315M
News
Ono Pays Kai $13M for Japanese Rights to Phase II Secondary Hyperparthyrodism Drug
News
Ortho-Clinical Diagnostics Granted FDA Approval for Intact Parathyroid Hormone Assay
Bioprocessing
Formatech to Fill and Finish One Lot of KAI Pharmaceuticals’ SHPT Drug at No Charge
News
Mitsubishi Tanabe Pharma Takes Stake in Cytochroma
Scroll Up
Scroll Up
